HTT and Huntington disease: Thus far, efficient strategies for treating experimental models of HD include 1) the delivery of small molecules or nucleic acids to target aggregate formation; 2) the degradation of mutant Htt; and 3) the elimination of protein interactions and cellular events disrupted by mutant Htt [23].